Cite
MLA Citation
Jason Fangusaro et al.. “LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B.” Neuro-oncology, vol. 21, n.d., pp. ii98–ii99. http://access.bl.uk/ark:/81055/vdc_100094056408.0x000014